11:18 AM EDT, 09/17/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending modestly lower late Tuesday morning, declining 0.16% to 1,445.76 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company Genfit ( GNFT ) and pharmaceutical company Ascendis Pharma ( ASND ) , which rose 6.8% and 5.7% respectively. They were followed by internet advertising firm Criteo ( CRTO ) and biotech firm BioNTech (BNTX), which increased 2.3% and 0.5% respectively.

The decliners from continental Europe were led by furniture maker Natuzzi (NTZ) and medical device maker EDAP TMS ( EDAP ) , which fell 6.7% and 3.3% respectively. They were followed by biotech firm Evaxion Biotech ( EVAX ) and biopharmaceutical company DBV Technologies ( DBVT ) , which lost 2.8% and 1.5% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Biodexa Pharmaceuticals ( BDRX ) and Akari Therapeutics ( AKTX ) , which were up 2% and 3.6% respectively. They were followed by pharmaceutical company Silence Therapeutics ( SLN ) and insurance company Prudential (PUK), which increased 3.4% and 1.3% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company NuCana ( NCNA ) , which tumbled 31.4%, followed by tobacco company British American Tobacco ( BTI ) , which was down 2.7%. Pharmaceutical company GSK (GSK) and medical device maker Smith & Nephew ( SNN ) dropped 1.7% and 1.2% respectively.